How to identify great biotech companies. Also my track record below. 1. Undervalued (low market cap vs assets and market potential) 2. Solid management (biotech experience, CEO track record and reputation, not too many turnovers) 3. Great pipeline versus what’s currently available (look for “first and only” or best in class potential. 4. Solving a big unmet need 5. Incremental successes through various stages of clinical trials 6. Strong upcoming catalysts 7. Positive interactions with FDA 8. Buyout or partnership potential 9. Similar compounds performing successfully on the market 10. Current partnership with a big pharma company or companies 11. Revenue generating 12. Possess a platform not just a drug 13. Stable earnings or in upward trend 14. Low debt 15. Low dilution risks but realize that it is part of life in biotech 16. Be patient and don’t panic. Every biotech company goes through rough patches or setbacks. As long as the solid fundamentals of the company haven’t changed, don’t panic! 17. Set your goals for each tickers (entry+exit strategies). Price goes up and down. I can’t give you financial advice. I am not a financial advisor. Biotechs are very volatile. Take profits or wait for bigger gains. It’s up to you. Remember the price may drop if you decide to wait or it may go up a lot! No one knows. 18. Know your risk tolerance. Don’t go all in on any tickers imo. 19. Remember to set your goals for entry and exits. If the ticker price goes up and you decided to hold for bigger gains then you are also taking risks of downside movements. However, many times it keeps going up. I provide in depth research and analysis. I don’t tell you how to trade. Please take full responsibility of your trade. Buy, hold, sell, it’s up to you. Feel free to compare my record to the paid discords. As promised, I will use my pharmaceutical experience to help us make profits in a very risky sector. You have to understand the science, clinical trials, SEC filings, management, product launches and so many nuances in biotech in order for you to try to beat the odds. I provide this to our community for free. All I ask is for us to be civil and kind to each other no matter the circumstances. And if you win, please donate to St Jude Hospital where they treat kids with cancer for free. MY TRACK RECORD. WILL BE UPDATED MONTHLY. 1. $VKTX - (Nov 2024) $11.60 - $99.41. Current Price $51.61 2. $ARQT - (Dec 2023) $2.43 - $13.17. Current price $10.44 3. $CALT - (Dec 2023) $21.60 - $41.90. Current price $39.01 4. $IONS - (Dec 2023) $49.30 - $54.55. Current price $46.09 5. $FUSN - (Dec 2023) $9.10 - $21. I also correctly predicted that $FUSN would be bought out by $AZN AstraZeneca. I predicted that the buyout would be $3B-$5B. The buyout price was $2.4B. Hint: I know AstraZeneca very well. $FUSN no longer exists. It’s now part of AstraZeneca. 6. $IOVA (Feb 2924) $9 - $18.33. Current price $7.28 7. $AQST - (Feb 2024) $2.48 -$6.23. Current price $2.49 8. $LUNR - (Feb 2024) $5.30 - $13.25. Current price $3.55 9. $DAWN - (Apr 2024) $13.96- $18.07. Current Price $13.71. 10. $XFOR - (Apr 2024) $.93 - $1.35. Current price $.55 11. $ARQT - (June 2024) $8.69 - $10.44(current price)

@America4Life72 Wow very generous of you my friend. Will be praying for Kai!

@America4Life72 Beauty! Thanks brother!

Thank you Nikos!

Haha. Same guy. Same silly argument. What is a compromised patient? What is high? What is low? What does compromised having to do with anything. Why didn’t the FDA talk about “compromised” patients in its feedback? Anaphylm can be given to anyone in any condition. Anaphylm doesn’t need to be swallowed. The drug is absorbed directly from the mucosa into the bloodstream. NO SWALLOWING REQUIRED.

@peter_paone Amen!

@Steven_Liekens I hope so. The company has a great opportunity to destroy shorts here during Q4 earnings.

@Rushing9000 Yes we will!

@Steven_Liekens It’s heavily shorted. Hopefully Q4 earnings will trap shorts.

$AQST - On the Oppenheimer Healthcare Conference, the host, Francois Brisebois confesses that he tried to nitpick Anaphylm’s data to find something negative, but doctors told him, “Stop trying to nitpick it. We struggle with this molecule. This is the most convenient thing we’ve ever seen.” Sherry Korczynski the Senior VP of Sales and Marketing said, “That’s very consistent with our market research. When given the option, physicians, caregivers and patients alike choose Anaphylm for that very reason. It’s so easy to carry and so easy to use. Current epinephrine options (not easy)! vs the future (very easy) with Anaphylm. If you are an investor or thinking about investing in $AQST you should take a look at this webcast. This in my opinion is the most impactful webcast that I have watched since I called $AQST last February!

@ivobuild Thanks for the follow and a belated welcome to the 🐉 family! Indeed, exciting times ahead my friend.

Thank you brother. People don’t realize patience is one the most important ingredients for success trading and investing. So many give up when the share price is beaten down. That’s the opposite of what they are supposed to do. So many exciting things ahead for $AUR and $AQST. Although the time horizon is longer for $AUR, it will be a great investment long term. I am very happy for you! People on social media are fickle. They love you when the stock price goes up and bashes you when down. What I do is to be true to myself and know what I do best on this platform- to provide in-depth research using my pharma experience FOR FREE. The only request that I make is if people made profits that they would donate some to St Jude Hospital. That’s it!

@ConfuciusTrades I have no idea. Shorts better get out of the way or they will be crushed

@orlando2766 @hkd_tweets Thanks. I saw the same thing.

@Billw4th It has moved up and down in the last 12 months. Each time the move is over 100% or even over 200% at $6.23. Now that it’s get close to approval of their most important drug and a great pipeline, I believe it will be in double digits by end of year.